Delivery Order SPE2DB22D2007-SPE2DB24FJ3VD

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Zolmitriptan 5 mg nasal spray, a migraine medication, with a ceiling value of $26,235.51. The contract has an ultimate completion date of August 21, 2024 and is a firm-fixed-price contract. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,160.17 delivery order is for the supply of 4,566,546,048 units of Zolmitriptan 5 mg nasal spray, a medication used to treat migraines. The contract has a firm fixed price and runs through November 2024. This delivery order is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Zolmitriptan 5 mg nasal spray, a medication used to treat migraine headaches. The delivery order has a ceiling value of $5,275.40 and a completion date of January 9, 2024. The contract is a firm-fixed-price agreement with no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,612.21 firm-fixed-price delivery order is for the supply of Zolmitriptan 5 mg nasal spray, a medication used to treat migraine headaches. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $62,444.36 firm-fixed-price delivery order is for the supply of Zolmitriptan 5 mg nasal spray, a medication used to treat migraines. The contract has a completion date of July 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $11,212.87, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zolmitriptan 5 mg nasal spray, a medical product used for the treatment of migraines. The contract has an ultimate completion date of July 10, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,199.96 delivery order is for the supply of Zolmitriptan 5 mg nasal spray, a pharmaceutical product, with a period of performance through October 2023. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award is for the delivery of 4,563,284,097 units of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,615.41, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 9, 2024. The contract has an ultimate completion date of January 10, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Zolmitriptan 5 mg nasal spray to the Defense Logistics Agency (DLA), a defense agency. The $2,042.23 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZOLMITRIPTAN 5 MG NASAL SPRAY 6S, a pharmaceutical product, with a ceiling value of $5,687.33 and a completion date of June 12, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ3VD
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,363.51, is for the delivery of Zolmitriptan 5 mg Nasal Spray 6S, a migraine medication.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract does not have a set-aside designation, indicating open competition. The ultimate completion date for this delivery order is July 1, 2024.

Generated 5/17/25, 10:15 AM